BioSplice Therapeutics, Inc. — Form D
BioSplice Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-03. Industry: Pharmaceuticals.
Offering
- Filed: 2021-03-03
- Form: D
- Accession: 0001848940-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Revenue range: Decline to Disclose
- SEC file number: 021-391093
Issuer
- Name: BioSplice Therapeutics, Inc.
- CIK: 0001848940
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 9360 TOWNE CENTRE DRIVE, SAN FRANCISCO, CA, 92121
- Phone: 858-926-2900
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Joy Ghosh | Director | San Diego, CA |
| Osman Kibar | Executive Officer | San Diego, CA |
| Arman Oruc | Executive Officer | San Diego, CA |
| Kyle Rasbach | Director | Boston, MA |
| Yusuf Yazici | Executive Officer | San Diego, CA |
| Susannah Gray | Director | San Diego, CA |
| Osman Kibar | Director | San Diego, CA |
| Karen McGinnis | Director | San Diego, CA |
| Scott Bulcao | Executive Officer | San Diego, CA |
| Darrin Beaupre | Executive Officer | San Diego, CA |
| Troy Cox | Director | San Diego, CA |
| Gur Roshwalb | Director | San Diego, CA |
| Erich Horsley | Executive Officer | Cambridge, MA |
| Cevdet Samikoglu | Director | San Diego, CA |
| Cevdet Samikoglu | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More